Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Julie Sawyer Montgomery
CEOJulie Sawyer Montgomery
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
161.32B
Market cap161.32B
Price-Earnings ratio
38.29
Price-Earnings ratio38.29
Dividend yield
0.65%
Dividend yield0.65%
Average volume
5.30M
Average volume5.30M
High today
$238.13
High today$238.13
Low today
$228.17
Low today$228.17
Open price
$233.80
Open price$233.80
Volume
5.01M
Volume5.01M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$160.93
52 Week low$160.93

Stock Snapshot

The current Danaher(DHR) stock price is $229.48, with a market capitalization of 161.32B. The stock trades at a price-to-earnings (P/E) ratio of 38.29 and offers a dividend yield of 0.65%.

On 2026-10-22, Danaher(DHR) stock moved within a range of $228.17 to $238.13. With shares now at $229.48, the stock is trading +0.6% above its intraday low and -3.6% below the session's peak.

Trading activity shows a volume of 5.01M, compared to an average daily volume of 5.3M.

The stock's 52-week range extends from a low of $160.93 to a high of $242.80.

The stock's 52-week range extends from a low of $160.93 to a high of $242.80.

DHR News

Benzinga 31m
Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings - Benzinga

...

Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings - Benzinga
TipRanks 7h
Danaher price target raised to $270 from $255 at BofA

BofA raised the firm’s price target on Danaher (DHR) to $270 from $255 and keeps a Buy rating on the shares. Management provided initial 2027 framing of 4%-5% c...

TipRanks 19h
Danaher Earnings Call Highlights Margin Strength, AI Push

Danaher Corporation ((DHR)) has held its Q3 earnings call. Read on for the main highlights of the call. Danaher Corporation’s latest earnings call struck a broa...

Analyst ratings

86%

of 28 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More DHR News

The Motley Fool 23h
Why Danaher Stock Bounced Higher Today

Better-than-expected quarterly profitability was the engine driving Danaher (DHR +4.29%) stock higher on Tuesday. Cheered by the company's estimates-beating res...

Why Danaher Stock Bounced Higher Today
The Motley Fool 1d
Danaher: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Oct. 21, 2026, Danaher (DHR +2.87%) raised its full-year earnings per share (EPS) guidance following higher thi...

Danaher: 3 Key Takeaways for Long-Term Investors
Seeking Alpha 1d
Danaher drops after Q3 revenue miss amid CEO transition

Danaher (DHR) shares fell more than 4% in premarket trading on Wednesday after the life sciences giant missed Street forecasts with its Q3 2026 revenue, as the...

Danaher drops after Q3 revenue miss amid CEO transition
TipRanks 1d
Danaher sees Q4 core revenue up 4%-5%

Sawyer Montgomery continued, “Danaher (DHR) has built a strong foundation, and the time I’ve spent with our teams and customers during my transition into the CE...

Benzinga 3d
Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Danaher Corporation (NYSE:DHR) will release earnings for its third quarter before the opening bell on Wednesday, Oct. 21. Analysts expect the company to report...

Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Simply Wall St 4d
How Investors May Respond To Danaher NVIDIA Lab AI Partnership

Danaher has entered a broad collaboration with NVIDIA to integrate accelerated computing and AI into selected scientific instruments and lab workflows, and is a...

How Investors May Respond To Danaher NVIDIA Lab AI Partnership
Simply Wall St 5d
Danaher Stock Looks Reasonably Priced After Its AI Lab Launch

has moved back into focus after a period where long term shareholders saw the stock fall 15.4% over five years, and the key issue now is whether the current pri...

Danaher Stock Looks Reasonably Priced After Its AI Lab Launch

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.